Va. Court Orders FDA To Reconsider Mifepristone Restrictions
A Virginia federal judge held that a 2023 regulation by the U.S. Food and Drug Administration unlawfully placed prescribing restrictions on the abortion drug mifepristone, agreeing with a group of abortion...To view the full article, register now.
Already a subscriber? Click here to view full article